TNS includes thousands of participants with volumetric magnetic resonance imaging, amyloid and tau positron emission tomography imaging, information on cerebrovascular pathology, Lewy body disease, and limbic‐predominant aging‐related TDP‐43 encephalopathy neuropathologic change (LATE‐NC), as well as numerous other outcomes. This evidence concerns the gene MAPT and Lewy body dementia.